Synlab

What Synlab does

SYNLAB Italia S.r.l. is the Italian operating subsidiary of the European diagnostics group SYNLAB Holdco GmbH, headquartered in Monza. The company operates an integrated outpatient diagnostic network across 8 Italian regions (Lombardia, Veneto, Friuli Venezia Giulia, Emilia Romagna, Liguria, Toscana, Lazio, Campania), delivered through wholly-owned medical centers, blood collection points (Punti Prelievo), partner centers (Centri Partner) in four additional regions, and a home blood draw service. Its service portfolio spans routine laboratory analyses, advanced medical imaging (MRI, CT, PET, mammography, scintigraphy, ultrasound, X-ray), specialist consultations, genetic testing including the neoBona NIPT line, women's health (SYNLAB Lei), COVID-19 testing, and corporate occupational health (Servizi alle aziende).

The technology stack combines centralized laboratory processing (e.g., the Castenedolo genetics hub leading the EU-funded V∀MPiRE AI-driven Parkinson's early-detection program) with consumer-facing digital platforms: the MySynlab and SYNLAB mobile apps, online booking portals (syncoda.synlab.it, online.synlab.it), and the shop.synlab.it e-commerce channel for self-purchased check-up packages. Patient records and results are delivered digitally across the network.

SYNLAB Italia makes money primarily through fee-for-service, unit-priced diagnostic and imaging transactions paid by individual patients (B2C) and, to a lesser extent, corporate clients (B2B occupational health). Pricing is publicly disclosed for selected COVID tests (€35-65 antibody panels, €50 PCR) and otherwise varies by region, test type, and service. Regional growth has been driven by acquisitions including Med Srl (2019, Tuscany) and SDN (2021, Campania nuclear medicine), with the October 2025 opening of SYNLAB Manifattura Firenze representing the largest organic facility investment to date.

Name

Synlab

Legal name

SYNLAB Italia S.r.l.

Website

https://synlab.it

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

SYNLAB Italia is a nationwide outpatient diagnostic network offering laboratory testing, medical imaging, genetic analysis, and specialist consultations across 8 Italian regions, serving primarily individual patients and corporate occupational health clients through owned centers, partner sites, and digital booking platforms.

Ownership category

akta.pro rank

Product category

Medical Diagnostic Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151), Medical and Diagnostic Laboratories (6215)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Reference & Esoteric Testing Laboratories (HLAFAMAJ)

akta.pro secondary industries

Central Laboratory Services (Core Lab Operations) (HLAGAEAA), Central Laboratory & Clinical Trial Testing CROs (HLAGAAAE), Clinical Research & Trial Central Laboratories (HLAFAMAL)

Keywords

• Diagnostic laboratory services
• Medical imaging services
• Clinical pathology testing
• Occupational health services
• Genetic and prenatal testing

Headquarters

HQ city

Monza

HQ country

Italy

HQ region

Europe

Offices9 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Clinical Laboratory Testing Services: Revenue generated from blood tests, clinical analyses, and laboratory diagnostic services provided at SYNLAB centers and partner locations
2. Medical Imaging and Diagnostics: Revenue from imaging services including radiology, MRI, CT scans, mammography, PET scans, and scintigraphy performed at SYNLAB Medical Centers
3. Specialist Medical Consultations: Revenue from specialist medical appointments across various disciplines including cardiology, gynecology, dermatology, and other outpatient services
4. Corporate/Occupational Health Services: Services provided to businesses including employee health screenings, workplace diagnostics, and occupational medicine compliance testing
5. COVID-19 Testing Services: PCR molecular tests, antibody tests (IgG, IgM), and neutralizing antibody tests offered during and post-pandemic period
6. Home Blood Collection Services: At-home blood draw services for patients with mobility issues or preferences, with sample processing at SYNLAB facilities

Pricing tiers

Go-to-market motion3 records

Distribution channels5 records

Marketing channels7 records

Core offering

SYNLAB Italia provides integrated medical-diagnostic services in Italy through owned medical centres, blood collection points, partner laboratories and digital platforms. Core offerings include routine and specialised laboratory analyses, non-invasive prenatal testing (neoBona), diagnostic imaging (MRI, CT, X-ray, ultrasound, mammography, PET, scintigraphy), specialist medical consultations, genetic analyses, COVID-19 PCR and serology testing, and home blood-draw services. A separate corporate line supplies occupational-health screening and workplace diagnostics to businesses, while EU-funded research (V∀MPiRE) extends the portfolio into early-detection in-vitro diagnostics.

Product overview

SYNLAB is a medical diagnostics company operating an integrated diagnostic network across Italy. The company offers a comprehensive portfolio of diagnostic services organized into several core product lines: (1) Laboratory Analysis Services (Analisi di Laboratorio) providing routine and specialized blood/clinical tests at collection points nationwide; (2) Genetic Analysis Services including the neoBona non-invasive prenatal testing (NIPT) line; (3) Clinical Diagnostic Services (Polyclinics) offering specialist consultations; (4) Diagnostic Imaging services encompassing radiology, ultrasound, CT, MRI, mammography, PET, and scintigraphy; (5) COVID-19 testing services; (6) Women's health services (SYNLAB Lei); (7) Corporate/Occupational health services; and (8) Home blood draw services. Digital access is enabled through the MySynlab APP and SYNLAB APP for appointment booking and results access, plus an e-commerce platform (shop.synlab.it) for online check-up purchases. The network operates across eight Italian regions (Lombardia, Veneto, Friuli Venezia Giulia, Emilia Romagna, Liguria, Toscana, Lazio, Campania) plus partner centres in additional regions.

Differentiator

Problem solved

Functional benefit

Brands

• neoBona: Non-invasive prenatal tests (NIPT) using maternal blood sample
• MySynlab
• SYNLAB APP

Products and services

• Analisi di Laboratorio (Laboratory Analysis Services) Comprehensive laboratory testing services including blood tests, clinical chemistry and routine diagnostic analyses available at SYNLAB's collection points and laboratories across Italy. Targeted at general public patients and GP referrals.
• Diagnostica per Immagini (Diagnostic Imaging) Medical imaging services including X-ray (RX), ultrasound, CT (TAC), MRI (open or closed), MOC bone densitometry, mammography, PET and scintigraphy, performed at SYNLAB Medical Centers. Targeted at patients referred by GPs/specialists for advanced imaging.
• neoBona (Non-Invasive Prenatal Test) Non-invasive prenatal test (NIPT) using a maternal blood sample to screen for chromosomal abnormalities, offered as part of the genetic analysis portfolio. Targeted at expectant mothers and obstetricians.
• Analisi Genetiche (Genetic Analysis) Predictive genetics and genetic testing services beyond NIPT, including hereditary-disease risk analysis and other genetic panels. Targeted at patients and clinicians seeking genetic diagnostics.
• Servizi Clinico Diagnostici (Clinical Diagnostic Services / Polyclinics) Multi-specialty outpatient clinic services providing specialist consultations (cardiology, gynaecology, dermatology, etc.) and diagnostic procedures across various medical disciplines. Targeted at patients seeking specialist consultations alongside diagnostic testing.
• SYNLAB Lei (Women's Health Services) Specialised women's health services including gynaecological examinations, obstetrics and related diagnostic services, marketed under the SYNLAB Lei sub-brand. Targeted at female patients seeking integrated women's health.
• Servizi alle Aziende (Corporate / Occupational Health Services) Occupational health services, workplace medical examinations and corporate health programmes delivered to Italian businesses. Targeted at companies needing employee health surveillance, regulatory compliance and wellness programmes.
• Prelievi a Domicilio (Home Blood Draw Services) At-home blood-draw service in which nurses visit patients at home to collect samples, with results delivered to the nearest SYNLAB facility. Targeted at patients with mobility limitations or those preferring home service.
• Test COVID-19 (Molecular PCR and Serological) COVID-19 molecular testing (Real Time PCR swab) and serological antibody tests (IgM-IgG) performed at SYNLAB centres across Italy. Targeted at individual patients, travellers and employers needing screening.
• MySynlab APP Mobile app for booking blood draws and medical analyses at SYNLAB centres and blood-collection points, with email/SMS confirmations. Targeted at individual patients in Italy.
• SYNLAB APP Comprehensive mobile application enabling booking of analyses, specialist appointments, viewing of test results and access to invoices. Available in Tuscany, Emilia-Romagna, Liguria and Campania (for collection points) with planned national expansion. Targeted at individual patients across Italy.
• shop.synlab.it (Online Check-Up Shop) Online e-commerce platform for purchasing laboratory check-up and health-screening packages with online booking and digital result delivery. Targeted at consumers seeking self-directed preventive health purchases.

Quantifiable outcome

• Over 200,000 patients served annually at flagship Florence location
• +1 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Six partnerships are on record, tiered minor and core.

• Poliambulatorio LametinominorChannel Partner/ Reseller/ DistributorPartner center in Calabria (Lamezia Terme) providing laboratory diagnostic services integrated with SYNLAB systems and quality standards
• Laboratorio di Analisi Cliniche Dr CusmaiminorChannel Partner/ Reseller/ DistributorPartner laboratory in Puglia (Bari) providing clinical analysis services as part of the SYNLAB partner network
• Istituto RaimondiminorChannel Partner/ Reseller/ DistributorPartner facility in Sicilia (San Cataldo and Caltanissetta) integrated into SYNLAB's diagnostic network
• Laboratorio Analisi ValdèsminorChannel Partner/ Reseller/ DistributorPartner laboratory in Sardegna (Cagliari) providing laboratory services under the SYNLAB partner model
• EU (European Union) - VαMPiRE ProjectcoreStrategic or Co-development PartnerSYNLAB is leading the genetic analyses component of the VαMPiRE project, a European Union-funded initiative with €8 million in EU funding to develop an in vitro diagnostic test for early detection of Parkinson's disease. The project involves 13 European partners plus one Australian associate, studying α-synuclein isoforms in 600 PD patients and 600 healthy individuals using advanced AI models
• Eurofins ScientificminorOthersMarket context: Eurofins Scientific acquired SYNLAB's clinical diagnostics operations in Spain in April 2025, indicating competitive dynamics in the European diagnostic market

Scale indicators5 records

Recent moves8 records

Expansion highlights5 records

Broad incumbents

• Quest Diagnostics: Largest US clinical laboratory services company, globally identified alongside SYNLAB as a key player in the cholesterol and broader diagnostic testing market. Comparable for routine and esoteric testing capabilities, R&D investment, and reference laboratory operations.
• Synlab International GmbH: Parent group of SYNLAB Italia, operating one of Europe's largest medical diagnostics networks with clinical labs and imaging across 30+ countries. Comparable as the broader platform that defines service standards, technology stack, and capital allocation for SYNLAB Italia.
• Labcorp (Laboratory Corporation of America): Major global clinical laboratory network offering routine, esoteric, and anatomic pathology diagnostics plus early development services. Comparable to SYNLAB for reference lab operations, broad test menu, and clinical trial testing capabilities.
• Sonic Healthcare: Global diagnostic laboratory and radiology operator with European presence, offering clinical pathology, imaging, and specialty testing. Comparable as a multi-modality, multi-country diagnostic network with similar scale ambitions to SYNLAB group.
• Eurofins Scientific: Global leader in bioanalytical testing and clinical diagnostics with extensive European lab footprint, identified as a direct competitor in cholesterol testing. Recent acquirer of SYNLAB's Spain operations, demonstrating competitive overlap and M&A interest in the same market.

Direct peers

• Istituto Diagnostico Italiano (IDI): Major Italian outpatient diagnostic network offering laboratory analysis, imaging, and specialist consultations with multiple Rome-area locations. Comparable to SYNLAB Italia in combining laboratory, imaging, and specialist visits in a single integrated network serving DTC patients.
• Unilabs Italia: Italian subsidiary of European diagnostic group Unilabs, providing clinical laboratory services, imaging, and pathology across multiple Italian regions. Competes with SYNLAB Italia on laboratory services, specialty testing, and corporate occupational health contracts.
• Cerba Healthcare Italia: Italian arm of the European Cerba network, offering reference and routine clinical laboratory services including specialty and esoteric testing. Directly comparable as a multi-region Italian diagnostic lab operator with central laboratory infrastructure and physician/customer base overlap.
• Lifebrain: Italian clinical laboratory network providing routine and specialized diagnostic testing across multiple regions with blood collection points and home sample collection. Directly competes with SYNLAB Italia in the same Italian DTC and physician-referred lab market with comparable service model.

Regional players

• Medipass / RBM Group: Italian diagnostic group operating laboratories and outpatient clinics with regional concentration. Comparable in operating an Italian regional diagnostic network, though smaller and more geographically concentrated than SYNLAB Italia.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/synlabitalia
• LinkedInit.linkedin.com/company/synlab-italia-srl

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries10 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Synlab